SUNG WHANG: Open Payments
NPI 1053750034 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$91 in 4 payments from 4 companies in 2025. Trend: 2023 $19 · 2024 $182 · 2025 $91
Food & beverage: $91
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 1 | $29 |
| Genentech USA, Inc. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: Ohtuvayre, Xolair, NUCALA, OFEV.
Industry payments across PA — which companies pay providers there.
